News
This mid-year school holiday, Ikano Centres and Mattel invites Malaysians to embark on a journey of imagination, creativity, and excitement with the Play Without Limits: A Mattel Adventure cross ...
As a moderator for NACE’s Conversations in Dermatology, I am thrilled to learn about the latest advances in the diagnosis and treatment of psoriasis, PN, and CSU from 3 world-renowned experts ...
A Harvard-trained dermatologist warns that persistent pimples and spots that bleed easily could be signs of basal cell carcinoma, the most common type of skin cancer.
Let’s face it — your pimple may be more problematic than you realize. A Harvard-trained dermatologist warns that some benign-seeming blemishes could be cancerous. Dr. Daniel Sugai urges ...
DERM (Deep Ensemble for Recognition of Malignancy), developed by Skin Analytics, analyses images to assess and triage skin lesions, potentially redirecting benign cases to non-urgent pathways.
Dr. Oma Agbai, a board-certified dermatologist and professor at UC Davis, joined the KCRA 3 News at noon to break down these concerns.
Mumbai, Maharashtra, India: CeraVe, developed by dermatologists and the #1 Dermatologist recommended skincare brand in the US, has introduced a ‘Derm On-The-Go’ initiative with an aim to make ...
Dr. Doris Day, a board-certified dermatologist, has barely any wrinkles at 62. She has had cosmetic treatments but said anyone can have youthful-looking skin. Day's tips include using an SPF cream ...
Journey Medical Corporation (DERM)’s share was trading at $4.98 as of Feb 19th. DERM’s trailing and forward P/E were 39.77 and 100 respectively according to Yahoo Finance. Journey Medical […] ...
Arcutis earned FDA approval for Zoryve foam in late 2023, clearing it for use to treat seb derm in patients ages 9 and up and making it the “first drug approved for seborrheic dermatitis with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results